A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. [PDF]
Cancer Cell IntSui B, Jin X, Zheng X.
europepmc +1 more source
Going viral: targeting glioblastoma using oncolytic viruses. [PDF]
Immunother AdvCoates K, Nibbs RJ, Fraser AR.
europepmc +1 more source
Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential. [PDF]
Front MicrobiolGupta A +3 more
europepmc +1 more source
Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]
Front ImmunolXianshu K +6 more
europepmc +1 more source
Combination therapy with oncolytic viruses for lung cancer treatment. [PDF]
Front OncolSun L, Zhao Q, Miao L.
europepmc +1 more source
Systemic Delivery Strategies for Oncolytic Viruses: Advancing Targeted and Efficient Tumor Therapy. [PDF]
Int J Mol SciXia Y, Li D, Yang K, Ou X.
europepmc +1 more source
Deciphering permissivity of human tumor ecosystems to oncolytic viruses. [PDF]
OncogeneSchoeps B, Lauer UM, Elbers K.
europepmc +1 more source
Oncolytic viruses cancer therapy
, 2008 Wild-type viruses with intrinsic oncolytic capacity in human includes DNA viruses like some autonomous parvoviruses and many RNA viruses. Recent advances in molecular biology have allowed the design of several genetically modified viruses, such as adenovirus and herpes simplex virus that specifically replicate in, and kill tumor cells.
openaire +1 more source
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer. [PDF]
Mol Cancer TherCudmore AO +11 more
europepmc +1 more source
Oncolytic viruses: a promising therapy for malignant pleural effusion and solid tumors. [PDF]
Front ImmunolWang X +5 more
europepmc +1 more source